Blood transfusions are an important part of modern medicine and can be divided into autologous (or autologous) and allogeneic transfusions. Autologous transfusion means taking your own red blood cells for retransfusion. This is as opposed to allogeneic transfusion, in which blood from an anonymous donor is transfused into a recipient. Autologous transfusions reduce the need for allogeneic transfusions.
Studies show that autologous transfusion is more cost-effective than allogeneic transfusion and improves clinical outcomes. On the basis of technology, the global automated blood transfusion device market can be divided into deposit transfusion, intraoperative blood dilution, and intraoperative and postoperative relief.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/22858
subdivision-
by technology
- Deposit blood transfusion
- blood dilution during surgery
- Intraoperative and Postoperative Relief
by application
- cardiac
- blood vessel
- Orthopedics
- trauma surgery
- liver transplant
by end user
- hospital
- Outpatient Surgical Center
- emergency room
- nursing home
- Different
For a complete list of market participants, please request a table of contents @ https://www.persistencemarketresearch.com/toc/22858
The market has been further segmented on the basis of application including cardiac, vascular, orthopedic, trauma surgery, and liver transplantation. The use of automated transfusion systems is second only to orthopedics in cardiac applications.
On the basis of end user, the global automated blood transfusion devices market has been segmented into hospitals, ambulatory surgical centers, emergency rooms, nursing homes, and others. Among these end users, hospitals account for the largest share and are expected to witness high growth.
On the basis of regional presence, the global Automated Blood Transfusion Devices market is segmented into five major regions. North America, Latin America, Europe, Asia Pacific, Middle East and Africa.
North America still dominates in the global automated transfusion device market as the number of surgeries and surgeries increases due to the increasing number of patients suffering from cardiovascular disease and the growing geriatric population. Emerging markets such as MEA and Latin America are expected to lag growth.
Pre-order now for exclusive analyst support @ https://www.persistencemarketresearch.com/checkout/22858
In most developed countries, the adoption of automated transfusion devices is emphasized by government agencies due to the risk of transmission of blood-related transfusion reactions and infections. Major manufacturers of automated transfusion devices identified in this market include Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, and Advancis Surgical.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – www.persistencemarketresearch.com